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Assessing Elementary Lesions in Gout by Ultrasound:
Results of an OMERACT Patient-based Agreement and
Reliability Exercise
Lene Terslev, Marwin Gutierrez, Robin Christensen, Peter V. Balint, George A. Bruyn, 
Andrea Delle Sedie, Emilio Filippucci, Jesus Garrido, Hilde B. Hammer, Annamaria Iagnocco,
David Kane, Gurjit S. Kaeley, Helen Keen, Peter Mandl, Esperanza Naredo, Carlos Pineda,
Bernd Schicke, Ralf Thiele, Maria Antonietta D’Agostino, and Wolfgang A. Schmidt, 
on behalf of the OMERACT US Gout Task Force
ABSTRACT. Objective. To test the reliability of the consensus-based ultrasound (US) definitions of elementary
gout lesions in patients.
Methods. Eight patients with microscopically proven gout were evaluated by 16 sonographers for
signs of double contour (DC), aggregates, erosions, and tophi in the first metatarsophalangeal joint
and the knee bilaterally. The patients were examined twice using B-mode US to test agreement and
inter- and intraobserver reliability of the elementary components.
Results. The prevalence of the lesions were DC 52.8%, tophus 61.1%, aggregates 29.8%, and erosions
32.4%. The intraobserver reliability was good for all lesions except DC, where it was moderate. The
best reliability per lesion was seen for tophus (κ 0.73, 95% CI 0.61–0.85) and lowest for DC (κ 0.53,
95% CI 0.38–0.67). The interobserver reliability was good for tophus and erosions, but fair to
moderate for aggregates and DC, respectively. The best reliability was seen for erosions (κ 0.74, 95%
CI 0.65–0.81) and lowest for aggregates (κ 0.21, 95% CI 0.04–0.37).
Conclusion. This is the first step to test consensus-based US definitions on elementary lesions in
patients with gout. High intraobserver reliability was found when applying the definition in patients
on all elementary lesions while interobserver reliability was moderate to low. Further studies are
needed to improve the interobserver reliability, particularly for DC and aggregates. (First Release
October 15, 2015; J Rheumatol 2015;42:2149–54; doi:10.3899/jrheum.150366)
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Gout is a common inflammatory joint disease and is caused
by the formation and deposition of monosodium urate
crystals (MSU) in joints or soft tissues. The diagnosis of
gout is conventionally based on the history, clinical exami-
nation, uric acid serum levels, and subsequent polarization
microscopy of joint or tophus aspirates. Polarization
microscopy is the definitive way to diagnose gout. In
suspected patients with gout without synovial effusion or
clinical tophi, the sampling of relevant material to examine
for MSU is challenging, and other diagnostic procedures
are warranted.
Uncontrolled hyperuricemia may be associated with
chronic kidney disease and cardiovascular disease with
subsequent increased morbidity and mortality1. This has
underlined the importance for an early, accurate diagnosis of
gout, and with the development of new therapeutic options,
imaging modalities have been investigated to determine
whether they may improve disease assessment. In this
respect, ultrasound (US) has been shown to be promising
because it allows direct visualization of the crystal deposits
and is also increasingly available in the clinical setting.
Although several published studies have highlighted the
involvement of US for the assessment of elementary compo-
nents in gout, a systematic literature review emphasized the
lack of definitions of US elementary lesions2. To improve the
use of US in the evaluation of gout, an Outcome Measures
in Rheumatology Clinical Trials (OMERACT) task force
subgroup was formed.
The first step in the standardization process of US as a tool
for diagnosis and monitoring of gout was to obtain
consensus-based definitions on US elementary lesions, as
revealed by the systematic literature review2 to be double
contour (DC), aggregates, tophi, and erosions. The consen-
sus-based definitions were obtained through a Delphi
exercise and tested in a subsequent Web exercise3. In the
latter, a good to excellent reliability was found for all lesions
except for aggregates, which was moderate when testing the
definitions on static images3. The second step in the standard-
ization process and the aim of our present study was to test
the reliability of the consensus-based definitions in known
patients with gout to ensure the pathologies to be present.
This second step is mandatory before it is possible to test the
US ability as a diagnostic tool.
MATERIALS AND METHODS
Study design and setting. Our present study was performed according to a
prespecified protocol. The reporting of the OMERACT reliability exercise
followed the recommendations from the Enhancing the QUAlity and
Transparency Of health Research network4 using the Guidelines for
Reporting Reliability and Agreement Studies statement5.
Ethics committee approval of our study was obtained from the Berlin
Medical Association (Berliner Ärztekammer, Eth-17/13). All patients gave
informed consent. Following the consensus-based definitions obtained
through a Delphi and Web exercise process, a workshop was conducted to
evaluate the reliability of detecting the elementary components in patients
and assessing agreement between sonographers with experience in US of
gout.
Measurements. The following definitions of the US elementary lesion
obtained from step 13 were tested in the patients with gout: (1) Double
contour: “Abnormal hyperechoic band over the superficial margin of the
articular hyaline cartilage, independent of the angle of insonation and which
may be either irregular or regular, continuous or intermittent and can be
distinguished from the cartilage interface sign”. (2) Tophus [independent of
location (e.g., extra-articular/intra-articular/intra-tendinous)]: “A circum-
scribed, inhomogeneous, hyperechoic and/or hypoechoic aggregation (which
may or may not generate posterior acoustic shadow) which may be
surrounded by a small anechoic rim”. (3) Aggregates [independent of
location (intra-articular/intra-tendinous)]: “Heterogeneous hyperechoic foci
that maintain their high degree of reflectivity even when the gain setting is
minimized or the insonation angle is changed and which occasionally may
generate posterior acoustic shadow”. (4) Erosions: “An intra- and/or extra-
articular discontinuity of the bone surface (visible in 2 perpendicular
planes)”3. Examples can be seen in Figure 1.
Patients. To ensure that all elementary lesions may be detectable, 8 patients
with polyarticular, tophaceous gout, verified by polarization microscopy
from the Medical Center of Rheumatology Berlin-Buch, volunteered for our
study. Their clinical data may be seen in Table 1. Each patient underwent a
bilateral B-mode US examination (including dynamic examination) of the
first metatarsophalangeal (MTP) joints, the cartilage of the intercondylar
region of the knees (ICR), and the proximal (PPT) and distal (DPT) parts of
the patella tendons. The MTP joints were examined dorsally, from medially
to laterally. The tendons were also examined from the medial to the lateral
aspect and at the enthesis where signs of erosive changes were also
evaluated. The lower extremities were chosen for feasibility reasons. All
examinations were performed during a morning and an afternoon session on
the same day, in the same room, using 8 Esaote MyLab Twice/Class
machines, equipped with 6-18 MHz broadband linear array transducers. The
B-mode settings of all 8 US machines were identical.
Ultrasonographers. Sixteen of the rheumatologists previously involved in
the development of the consensus-based US definitions for gout participated
in the workshop. All rheumatologists were experienced in musculoskeletal
US.
Outcomes and rating process. Each patient (numbered 1–8) was assigned to
1 machine (numbered 1–8), and the ultrasonographers (numbered 1–16) then
moved from 1 patient to the next in a predefined (randomized) sequence
with 13 min allocated for scanning and scoring the findings. All patients
were scanned twice by the same examiner to assess the intrareader reliability.
The data were collected immediately after the session to ensure no commu-
nication between examiners.
Statistical analysis. Intra- and interobserver reliability was estimated based
on Cohen κ coefficient. These κ coefficients and the corresponding 95% CI
were interpreted according to Landis and Koch6: κ values of 0–0.20 were
considered poor, 0.20–0.40 fair, 0.40–0.60 moderate, 0.60–0.80 good, and
0.80–1 excellent. Percentage of observed agreement (i.e., percentage of
observations that obtained the same score) and prevalence of the observed
lesions were also calculated.
Because our study used a hierarchical design, with repeated measures
across 8 patients and 16 rheumatologists, Cohen κ for measuring agreement
between 2 raters had to be extended according to Light and Fleiss for use
with multiple raters, as well as repeated measures within patients7,8. Thus,
we used a crossed design in which all raters (1–16) evaluated all patients (8)
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in duplicates (2 tests), in all anatomical positions (4 positions: DPT, ICR,
MTP1, and PPT), and on both sides of the body (right, left). The outcomes
were the facet of differentiation, and they were nested in patient and rheuma-
tologist. For intraobserver reliability, to adjust for the “clustered data” we
inflated the standard error (SE) of the κ estimate (tophus, aggregates, and
erosions) by multiplying the unadjusted SE with 2.828 (i.e., 8 × 16
independent observations rather than the apparent 1024 clustered observa-
tions); for DC, the unadjusted SE was multiplied by 2.000 (i.e., 8 × 16
independent observations rather than the apparent 512 clustered observa-
tions). Interobserver reliability was assessed by Light’s κ (mean κ across all
pairs of interobservers) based on the second test scenario8.
RESULTS
All patients were men with a mean age of 67 years (range
48–74) and all received urate-lowering therapy (Table 1). The
prevalence of lesions are listed in Table 2, showing that DC
and tophus are most frequently observed (> 50%), especially
in the ICR and MTP1, respectively, while aggregates and
erosions were observed in < 30% of the anatomical areas and
most frequently in the MTP1 joint for both.
Table 3 summarizes the results of the reliability of US
elementary lesions in patients. The intraobserver agreement
(absolute terms) was for tophi (87%, 891/1024), aggregates
(84%, 857/1024), erosions (87%, 889/1024), and DC (76%,
391/512). Further, the intra- and interobserver κ values are
shown. For the intraobserver reliability, the best reliability
per lesion was seen for tophus (κ 0.73, 95% CI 0.61–0.85)
and lowest for DC (κ 0.53, 95% CI 0.38–0.67). The results
for the interobserver reliability per lesion were best for
erosions (κ 0.74, 95% CI 0.65–0.81) and lowest for aggre-
gates (κ 0.21, 95% CI 0.04–0.37).
DISCUSSION
Because of the introduction of new treatment options for both
acute and chronic gout, research activities have focused on
developing validated outcome measures to evaluate treatment
effects. This has been the case, in particular, with regard to
tophus regression and joint inflammation, including joint
2151Terslev, et al: Reliability of US in gout
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Figure 1. Elementary US lesions of gout. US: ultrasound; T: tophus; DC: double contour; E: erosion; A: aggregate.
Table 1. Clinical data of the examined patients.
Patient Age, Yrs Disease Rheumatology Clinically Maximum Current Current
No. Onset, Yrs Care, Mos Involved Known Urate Treatment, 
Joint Urate Level, mg/d
Regions Level, mg/dl mg/dl
1 67 11 11 T, A, K, D, W, E 10.6 5.9 F 120, Co 1
2 74 5 2 T, K, D 5.8* 5.8 A 300, Co 1
3 65 19 1 T, A, K, D, W, E 8.2 4.9 F 80, Co 0.5
4 70 21 18 T, A, K, D, W, E 6.6* 4.8 A 300
5 72 7 31 T, A, K, E 12.4 3.8 F 120, Co 1
6 69 20 11 T, A, K 9.0 5.4 A 400, Co 0.5
7 68 28 2 T, A, K, D, W, E 8.1 5.5 F 120, Ca**
8 48 6 3 T, A, K, D, W, E 6.4* 3.5 F 120, P 1000, 
PRED 15
* Uric acid levels only available at time of gout attack and/or with uric acid–lowering therapy. ** The patient has
received a subcutaneous injection of 150 mg of Ca 6 weeks before. T: toes; A: ankles; K: knees; D: digits; W:
wrists; E: elbows; A: allopurinol; Ca: canakinumab; Co: colchicine; F: febuxostat; P: probenicid; PRED:
prednisolone.
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swelling9. For both chronic and acute gout, the suggested
variables in the OMERACT core domain set mentioned
above may be evaluated by US. To validate US as a possible
outcome instrument, we set out to standardize US by first
defining the US elementary lesions in gout. After the initial
step of defining the elementary lesions and test these on static
images of well-illustrated lesions3, the next step was to test
the reliability of the definitions in known patients with gout,
adding image acquisition to the exercise.
The intraobserver agreement was found to be good for all
lesions and moderate for the DC. The interobserver reliability
was fair for aggregates (0.21) and moderate for DC (0.47),
and good for the other components. These findings are in line
with previous studies on reliability for US lesions and
regions10,11, also in gout12. Aggregates are heterogeneously
described in the literature2 and are believed to be deposits of
crystals in the soft tissues not large enough to be defined as a
tophus3, while DC is created by the deposits of crystals on the
surface of the cartilage13 and may be detected by US in up to
60% of joints, including asymptomatic joints in patients with
gout14,15,16. In our study, the overall DC prevalence was 53%
(Table 2). The US definition obtained in the Delphi for aggre-
gates is less specific than the other definitions3 and was
proposed to define soft tissue hyperechogenicity often seen in
patients with gout2. Though the good intraobserver agreement
demonstrates that the individual sonographers know what to
score, they appear to have different perceptions of the
definition because the interobserver agreement is only fair.
Even when looking at the individual sites, there is no joint or
tendon site that has better reliability for detecting aggregates.
2152 The Journal of Rheumatology 2015; 42:11; doi:10.3899/jrheum.150366
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Table 2. Prevalence of observed gout lesions in the first and second round. Both overall prevalence per lesion and
prevalence of the lesions per site are given.
US Gout Lesions Observed Prevalence, % Positive Findings, n Total Observed Sites, n
Tophus
Overall 61.1 1251 2048
PPT 66.4 340 512
DPT 68.6 351 512
MTP1 89.5 458 512
ICR 19.9 102 512
Aggregates
Overall 29.8 611 2048
PPT 33.6 172 512
DPT 28.9 148 512
MTP1 45.5 233 512
ICR 11.3 58 512
Erosions
Overall 32.4 663 2048
PPT 21.7 111 512
DPT 16.6 85 512
MTP1 85.0 435 512
ICR 6.3 32 512
DC
Overall 52.8 541 1024
MTP1 49.4 253 512
ICR 56.3 288 512
US: ultrasound; PPT: proximal patellar tendon; DPT: distal patellar tendon; MTP1: metatarsophalangeal joint 1;
ICR: intercondylar region; DC: double contour.
Table 3. Overall intraobserver agreement and the intra- and interobserver reliability estimates for each of the
elementary gout lesions.
US Gout Overall Intraobserver Intraobserver Reliability, Interobserver Reliability,
Elementary Lesion Agreement, % κ (95% CI) κ (95% CI)
Tophus 87 0.727 (0.605–0.849) 0.691 (0.589–0.771)
Aggregates 84 0.611 (0.460–0.761) 0.209 (0.039–0.368)
Erosions 87 0.699 (0.566–0.832) 0.737 (0.647–0.807)
Double contour 76 0.526 (0.379–0.673) 0.469 (0.323–0.593)
US: ultrasound.
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The poor performance of the aggregate definition may
also partly be related to statistical factors. The prevalence of
aggregates was low overall, and this may explain the fair κ.
When the prevalence is very low or very high, low κ values
are obtained even though the overall agreements are high
(paradox κ)17. This is because with high prevalence, the
agreement expected by chance is very high and κ is the
remaining agreement obtained after discounting agreement
by chance. This may also partly explain the lower site
agreement for DC.
DC is perceived to be indicative of gout18. The reliability
for DC was moderate for both intra- and interobserver
agreement, which is in contrast to the interobserver reliability
of the DC in previous publications where it was found to be
excellent in local research groups14,15,18,19. This may partly
be related to more exercise time on pathological features in
small study groups and may indicate that more scanning time
together in a group is necessary. Further, the US definition
for DC is more detailed and the discrepancy between the
interobserver agreement found in the Web exercise and that
found in the patient workshop may in part be related to the
image acquisition and scanning technique. In static image
Web exercises, only clear images of the pathologies are
chosen, which might not always resemble the clinical setup
with patients. Another possible pitfall might be that the DC
may resemble cartilage interface, which can only be seen in
an area where the insonation angle is 90° and appears as a
white line on the surface of the cartilage. The DC is seen as
a white line — punctuate or linear — on the surface of the
cartilage, and also in areas where the insonation angle is <
90°, and will move with the cartilage during dynamic
exercise as the crystals are deposited on the surface of the
cartilage. Though this differentiation between cartilage
interface sign and DC is well known, it may have had an
effect on the findings during image acquisition in patients —
especially in the ICR where the presence of even a minimal
effusion makes the cartilage interface sign more frequent.
Further studies are needed to evaluate the optimal site for
cartilage pathology.
Not surprisingly, the reliability of erosions was good for
both intra- and interreader reliability, which can be explained
by a longstanding experience in the group scanning the
pathology from rheumatoid arthritis (RA). The exercise also
demonstrated a good intra- and interreader reliability for
tophus, which is an aspect of the urate burden in patients with
gout. However, aggregates were the lesions with the lowest
reliability both in the static image exercise3, but even lower
in patients, especially between observers. This raises the issue
of whether the definition is truly covering the US lesions it
is supposed to describe (soft tissue hyperechogenicity).
Because a tophus is also a collection of aggregates, there is a
risk that these 2 elementary lesions are overlapping and
impairing the agreement between observers. Further steps are
needed to improve the US definitions for aggregates before
it may be an elementary US lesion in gout as part of future
outcome measures. 
For DC, the reliability was moderate and further studies
are needed to improve the reliability by focusing on MTP
joint cartilage before the definitions may be used in multi-
center studies and before testing the diagnostic sensitivity of
US in gout20.
Future steps that include collaboration with histologists
may be beneficial to improve the definitions followed by Web
exercises with focus specifically on these 2 features (aggre-
gates and DC) in images resembling daily clinical situations.
Patient workshops are needed to develop optimal image
acquisition techniques, and finally the development of an US
atlas of pathological lesions may aid in the reliability process
because this has been found to highly increase reliability for
scoring synovitis in RA between sonographers21. 
Consensus-based US definitions of elementary lesions in
gout were tested in patients and showed high intraobserver
reliability, but lower interobserver reliability — especially
for aggregates. DC had lower interreader reliability than
tophus and erosions. Further studies are needed to explore
the US definition of aggregates for improving the reliability
between sonographers.
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